Merlintrader research directory · Non-biotech

Small and Mid Caps: $SPSC, $CLF, $FSLY and $PENG

Week of October 19–23, 2026. The same five company cases, re-examined at the October 16 close: a software consolidation that held, a steel producer reporting on October 19, a contract-supported trend and two technology advances that reversed sharply. Everforth ($EFOR) is the fifth case. Dated company evidence, cash-flow risks and chart conditions guide the research; none supplies a promised positive week.

5 casesResearch statuses and risks stated individually

-10.40%Previous five · Oct 9–16 price audit

-3.05%IWM · identical audit interval

Oct 16Latest completed U.S. session

Open the weekly listBrowse the research

Read the business, the cash and the market together

Small and mid caps can react sharply to financing, a single customer, operating leverage or a change in expectations. A higher share price does not resolve those risks. This week’s work separates reported operating progress from management forecasts, identifies where earnings and cash generation diverge, and keeps contract ceilings distinct from booked revenue.

The market backdrop weakened. From October 9 to October 16, IWM changed −3.05%, MDY −1.49% and SPY −1.97%. IWM’s $270.44 close was below SMA20 $279.31 and SMA50 $289.07, and its intermediate average declined 1.20% over ten sessions. MDY and SPY also closed below both averages. Small caps therefore lost more ground than large caps for a second consecutive week. The coming week has a light federal statistical calendar, so company results, starting with Cleveland-Cliffs on October 19, carry more of the information flow; the Federal Reserve’s October 27–28 meeting falls in the following week.

These are research comparisons, not a ranked model portfolio. The scope is U.S.-listed non-healthcare equities in an indicative $300 million–$10 billion market-value band. No allocation, entry recommendation, price objective or probability-of-success claim is made.

Five researched cases: confirmation, cash and timing

October 19–23 · closes through October 16

This edition re-examines the same five cases at the October 16 close instead of replacing them. Two of them, FSLY and PENG, lost more than 23% during the week and met the weakening conditions stated a week earlier; they remain visible with a changed status, because removing failed cases would make the record look better than it was. Detailed daily-price work covered 23 individual equities and three benchmark ETFs: the five cases and the 18 names checked in the previous edition. This is a finite editorial selection, not an exhaustive market ranking.

Consolidation, cyclicals and contracts · Reversed technology cases · Week-ahead calendar · Previous-edition audit · Other checked names

Ticker	Company	Oct 16 close · USD	Oct 9–16 price change	vs IWM · percentage points	Research status	Why it is on the list
$SPSC	SPS Commerce	85.25	+0.78%	+3.83 pp	Consolidation research · liquidity caveat	Held above rising averages while small caps fell; participation remains thin and third-quarter results are scheduled for October 29.
$CLF	Cleveland-Cliffs	12.12	-6.63%	-3.58 pp	Earnings week · recovery under test	Gave back part of the prior advance ahead of the October 19 results; the close sits on SMA20 and just above SMA50.
$EFOR	Everforth	38.36	+2.29%	+5.34 pp	Trend continuation · extension risk	Every close from October 13 held above last week’s $37.66 reference, but the $40.33 intraday high was not retained; third-quarter results are due October 28.
$FSLY	Fastly	22.47	-23.31%	-20.26 pp	Continuation thesis failed · reassessment	Closed below both averages after three large down sessions, meeting last week’s weakening conditions; no new issuer release accompanied the move.
$PENG	Penguin Solutions	57.10	-25.14%	-22.10 pp	Post-results reaction reversed · reassessment	Fell through the October 7 low and October 6 close cited last week and closed below SMA20, close to SMA50.

The prior-week return describes what happened before this edition. It does not predict next week. The fixed forward comparison is October 16 close to October 23 close, against IWM over the same interval. Its ending close is not yet available. All five cases, including the SPSC liquidity exception and the two reversed technology cases, remain in that future audit; no failed or unconfirmed name may be removed retrospectively.

Consolidation, cyclical earnings and contract evidence

$SPSC · SPS Commerce

Consolidation research · liquidity caveat: The software recovery held through a weaker market, with participation still thin

October 16 close $85.25 · SMA20 $82.83 · SMA50 $81.25 · volume/prior20 0.93×

Business evidence and timing. SPS Commerce connects retailers and suppliers through supply-chain software. Its July 30 release reported second-quarter revenue of $197.8 million, up 6%, recurring revenue growth of 6%, and adjusted EBITDA of $66.6 million, up 19%. These are results for the quarter ended June 30, not an October earnings update. On September 15, the company announced general availability of MAX, initially for Fulfillment and Visibility Management. That is an actual product milestone. The release does not provide a separately quantified MAX revenue contribution, so this edition does not add an assumed AI revenue stream to the reported business. On October 15, the company scheduled third-quarter results for October 29 after the market close, with a 4:30 p.m. ET call. July 30 quarterly results.

What has changed in the chart. The October 16 close of $85.25 was above SMA20 $82.83 and SMA50 $81.25. The intermediate average rose 3.51% over ten sessions. The stock gained 0.78% from October 9 while IWM fell 3.05%, a 3.83 percentage-point relative advantage. On October 16 it traded as high as $89.00, just below the $89.44 reference cited last week, before closing at $85.25, down 1.81% on the day. Its 2.92% distance above the short average remains modest. This keeps it a useful consolidation comparison, but it does not establish that its valuation is low. A less stretched price can still fall when earnings expectations reset.

The participation weakness persists. October 16 volume was 0.93 times the preceding 20-session average. The latest 20-session average was approximately 470,311 shares, below the preferred 500,000-share research threshold and lower than the 492,809 recorded a week earlier. SPSC therefore remains a disclosed liquidity exception, not a fully qualified high-volume technical selection. Liquidity should be assessed using actual spreads and depth as well as average turnover. Holding above rising averages while small caps fell is relative evidence; it is not a breakout supported by a broad increase in trading activity.

Financial quality and its limits. June 30 cash was $173.17 million. The 10-Q reported first-half stock-based compensation of $36.77 million and a $23.45 million loss on the sale of the 3P Revenue Recovery business. The July outlook incorporated about $10.5 million less second-half revenue from that disposal, with an expected neutral adjusted-EBITDA impact. GAAP quarterly EPS was $0.19 versus $0.52 a year earlier. The cash balance supports the business, but an adjusted earnings presentation and share repurchases are not proof that every measure of per-share profitability improved. June 30 Form 10-Q.

What would strengthen the case. Repeated closes above the short average, better participation and acceptance above the $89.00–$89.44 area would add evidence. The October 29 report is the next business check: recurring revenue, customer adoption, monetization of MAX and the gap between GAAP and adjusted earnings matter more than another general AI label. A price move accompanied by falling reported growth would need to be reassessed.

What would weaken the case. A sustained loss of the $82.83 short-average area would weaken the consolidation; the $79.91 ten-session low is the deeper observed warning. These are chart references, not entry or stop orders. Deteriorating software demand, weaker recurring revenue, disappointing monetization, or a larger gap between GAAP earnings and adjusted measures could outweigh the technical trend. Low relative volume also means that a favorable final candle alone should carry less weight.

The next observation that matters. The research question is whether the recovery develops into sustained demand for the shares while the business continues to deliver. The stock held its rising intermediate average during a week in which IWM fell more than 3%, which is constructive relative evidence. The October 29 results can confirm or contradict it, and a gap on the report can skip every chart reference. Neither observation creates an automatic decision for a reader; the purpose is to keep the next week’s interpretation tied to facts that can be checked.

Primary sources: July 30 quarterly results · September 15 MAX launch · June 30 Form 10-Q · October 15 earnings schedule. Company figures retain the reporting dates stated above; all chart figures use October 16 prices.

Blue: SMA20. Purple: SMA50. Green candles close at or above their open; red candles close below it. Lower bars show each session’s share volume. The chart contains historical observations, with no projected prices.

Source: daily bars through October 16, 2026. Moving averages calculated by Merlintrader from the same series. The displayed window is July 24–October 16; earlier observations supply the averages.

$CLF · Cleveland-Cliffs

Earnings week · recovery under test: The steel rebound gave back ground ahead of the October 19 report

October 16 close $12.12 · SMA20 $12.12 · SMA50 $12.01 · volume/prior20 1.40×

Business evidence and timing. Cleveland-Cliffs is a North American steel producer with substantial automotive exposure and an integrated production chain. July 23 second-quarter results reported revenue of $5.2 billion, operating cash flow of $230 million, a GAAP net loss of $134 million and adjusted EBITDA of $286 million. Management expected third-quarter adjusted EBITDA of approximately $575 million. That was guidance, not a reported third-quarter result. The issuer announced on October 1 that Q3 results are due before the market opens on Monday, October 19, with the call at 08:30 ET. The report now falls on the first day of this edition’s October 19–23 window. July 23 quarterly results.

Recent project news needs the correct horizon. An October 5 announcement described the Butler Works GOES expansion: a $200 million investment supported by a $75 million Department of Energy award, with completion expected in early 2028. The planned October 6 official visit has already passed. The project is relevant to electrical-steel capacity and transformer demand, but it is not immediate October earnings or a new cash receipt equal to the award. Those project terms come from the company announcement; disbursement and construction progress will need later disclosure.

What the chart now says. CLF closed at $12.12 on October 16, essentially level with SMA20 ($12.12) and slightly above SMA50 ($12.01). The intermediate average rose 0.87% over ten sessions, less than the 1.81% recorded a week earlier. The October 9–16 price change was −6.63%, trailing IWM by 3.58 percentage points. The decline came in steps: −2.18% on October 14 and −3.42% on October 15, when the stock traded as low as $11.67. October 16 volume was 1.40 times the preceding 20-session norm. The stock did not regain the $13.11 prior-20-session high cited last week; its October 12 high was $13.01. Part of the recovery has therefore been surrendered before the results rather than confirmed by them.

The financial test behind the price. An improvement in adjusted EBITDA can coexist with a net loss, interest costs and heavy capital demands. Positive operating cash flow is useful evidence, but it must ultimately cover investment needs and financing obligations. The July guidance provides a specific number for the October 19 report to test; the retreat before the report shows that expectations can move before any figure is published. This edition makes no consensus-beat claim because it does not have a verified, timestamped analyst-estimate set. It also does not infer a guaranteed gain from tariffs, government support or the presence of officials at a facility.

What would strengthen the case. Business confirmation would require the October 19 release to show the relationship among shipment volumes, realized pricing, production costs, cash generation and management’s next outlook, set against the approximately $575 million third-quarter adjusted EBITDA expectation published in July. A recovery back above the $13.22 prior-20-session high, with renewed relative strength, would improve the price evidence. A large adjusted-profit headline alone would leave open questions about recurring cash conversion.

What would weaken the case. A sustained close below the $12.12–$12.01 moving-average area would weaken the recovery; the $11.36 ten-session low is the deeper observed structure reference. Lower demand, weaker steel pricing, higher inputs, delayed projects or disappointing cash conversion could undermine the operating case. A gap after October 19 can skip chart references entirely. The scheduled event supplies a date on which evidence may change, not a guarantee that the information will favor the shares.

How to read the coming week. The useful distinction is between anticipation and delivery. The shares weakened before the report, while the quarter’s profit and cash figures are not yet published. A stock can rise after a result that looks weak in isolation if the outlook improves, and it can fall after meeting a published outlook if expectations had become more demanding. Until the release arrives, either scenario remains possible. The case therefore stays in the list as a cyclical earnings case with timing risk clearly visible, not as a promised positive catalyst.

Primary sources: July 23 quarterly results · SEC earnings exhibit · October 1 earnings schedule · October 5 Butler announcement. Company figures retain the reporting dates stated above; all chart figures use October 16 prices.

Blue: SMA20. Purple: SMA50. Green candles close at or above their open; red candles close below it. Lower bars show each session’s share volume. The chart contains historical observations, with no projected prices.

Source: daily bars through October 16, 2026. Moving averages calculated by Merlintrader from the same series. The displayed window is July 24–October 16; earlier observations supply the averages.

$EFOR · Everforth

Trend continuation · extension risk: Closes held above last week’s reference, with extension and a contract ceiling still to digest

October 16 close $38.36 · SMA20 $35.28 · SMA50 $33.32 · volume/prior20 0.83×

Business evidence and timing. Everforth's September 24 issuer announcement described a three-year, sole-source SUNet IDIQ expansion with a $148 million ceiling and a separate selection to research and prototype SUNet 2.0. The two developments are separate and do not show that the entire ceiling funds the new prototype. An IDIQ ceiling is a limit on potential work, not guaranteed funded orders, recognized revenue or cash. The previous edition correctly treated the announcement as a conditional event case. Its presence here reflects a changed chart, while the funding distinction remains the same. On October 14, the company scheduled its third-quarter call for October 28 at 4:30 p.m. ET. September 24 SUNet announcement.

The chart held its gains. The October 16 close was $38.36, above SMA20 $35.28 and SMA50 $33.32. SMA50 rose 6.67% over ten sessions. The stock gained 2.29% from October 9 while IWM fell 3.05%, a 5.34 percentage-point relative advantage. Every close from October 13 to October 16 was above the $37.66 prior high cited last week, including $39.52 on October 15. On October 16 the stock traded as high as $40.33, above the $39.74 prior-20-session high, but closed at $38.36, down 2.94% on the day. That is another intraday advance without a retained closing breakout above the new high.

Extension and volume limit the interpretation. The price is 8.73% above SMA20, less stretched than the 10.40% recorded a week earlier, while October 16 volume was 0.83 times the preceding 20-session average. This remains an extended continuation case, not a low-extension setup. Rising prices do not establish that buyers will continue to support the same valuation. Consolidation could improve the balance between price and trend without any new contract announcement. Conversely, a sharp reversal could expose how much optimism had accumulated. This distinction matters particularly when a single announcement becomes the dominant explanation for a move.

The business has not yet demonstrated a broad federal rebound. For the quarter ended June 30, the July 29 release reported revenue of $1.007 billion versus $1.021 billion a year earlier and adjusted EBITDA of $96.7 million versus $108.5 million. Federal trailing-twelve-month book-to-bill was 0.8. June cash was $152.9 million and balance-sheet long-term debt was $1.438 billion. These are dated balances before the July refinancing, not a current debt estimate. The new contract headline does not by itself overturn the weaker historical bookings and earnings figures. Future task orders and reported conversion need to supply that evidence.

What would strengthen the case. A less extended consolidation, followed by closes above $40.33 with better participation, would improve the continuation evidence. The October 28 results are the next business check: funded work, task-order timing and federal bookings would be more useful confirmation than repeating the total ceiling. Readers should distinguish commercial consulting demand from federal program exposure when considering future results: the segments do not necessarily respond to the same driver at the same time.

What would weaken the case. Repeated rejection near the $39.74–$40.33 area, followed by loss of the $35.28 short average, would weaken the continuation structure. The $33.80 ten-session low is a deeper observed warning, with the intermediate average at $33.32. Execution delays, funding uncertainty, weaker commercial demand or financing costs could change the business interpretation. A move back toward a moving average is not automatically a bargain; the reason for the move matters, and the balance sheet still deserves scrutiny.

The next observation that matters. The central research question is whether current price strength receives more support from operating evidence. A contract extension can support an existing revenue stream without producing an immediate step change in growth. A separate prototype can be strategically relevant before its commercial value is quantified. Treating every defense-related headline as the same catalyst would obscure those differences. The chart held up during a weak week for small caps, but the company must still show how its opportunities convert into revenue, profit and cash.

Primary sources: September 24 SUNet announcement · July 29 quarterly results · June 30 Form 10-Q · October 14 earnings schedule. Company figures retain the reporting dates stated above; all chart figures use October 16 prices.

Blue: SMA20. Purple: SMA50. Green candles close at or above their open; red candles close below it. Lower bars show each session’s share volume. The chart contains historical observations, with no projected prices.

Source: daily bars through October 16, 2026. Moving averages calculated by Merlintrader from the same series. The displayed window is July 24–October 16; earlier observations supply the averages.

Two technology cases after a sharp reversal

$FSLY · Fastly

Continuation thesis failed · reassessment: The edge-cloud advance reversed through both averages

October 16 close $22.47 · SMA20 $26.03 · SMA50 $24.98 · volume/prior20 0.85×

Business evidence and timing. Fastly provides edge delivery, security and related cloud services. A September 28 joint announcement described Fastly software running on Comcast's distributed network to support Peacock live events. The deployment is company-specific evidence of product use. The announcement does not disclose an incremental contract value or a separate Fastly revenue contribution. An October 8 issuer notice scheduled Q3 results after the November 4 market close, with a 16:30 ET call. Those earnings fall after this edition’s October 19–23 window. Form 4 filings show that the chief technology officer sold 40,041 shares on October 9 and 12 at weighted average prices between $26.62 and $30.07 under a Rule 10b5-1 plan adopted on June 4; pre-arranged sales of this kind are not, by themselves, evidence about the business. September 28 Comcast announcement.

Reported operations give the narrative substance. The August 5 release for the quarter ended June 30 reported revenue of $183.3 million, up 23%, and a GAAP net loss of $15.6 million. Quarterly operating cash flow was $39.3 million and company-defined free cash flow was $3.6 million. The 10-Q reported June cash of $89.8 million and marketable securities of $247.7 million. Those assets are not a current cash balance, and their date differs from that of the October price data. Strong revenue growth and positive cash flow are useful, while continuing GAAP losses remain part of the financial picture.

What the price now shows. FSLY closed at $22.47 on October 16, below SMA20 $26.03 and SMA50 $24.98. The October 9–16 price change was −23.31%, trailing IWM by 20.26 percentage points. The decline arrived in three large sessions: −9.80% on October 12, −7.72% on October 14 and −10.37% on October 16, when the stock traded as low as $21.90. Volume on October 16 was 0.85 times the preceding 20-session average, so the final drop did not come with unusually heavy turnover. The stock is now 13.66% below SMA20, the mirror image of the 13.66% extension above it a week earlier. The intermediate average still rose 2.86% over ten sessions, but it now sits above the price.

The reversal shows how valuation risk works. The relevant distinction is between usage, monetization and sustained profitability. A visible streaming deployment may increase confidence in the platform, but it is not a disclosed amount of revenue. The issuer’s releases and SEC filings show no new company disclosure between October 9 and October 16 other than insider filings (a Form 144 and a Form 4), so the primary record does not attribute the decline to a reported change in company economics. A sector-wide repricing or a change in expectations can move an extended stock without any company news. This edition supplies no analyst price target, short-squeeze estimate or probability of outperformance.

What would rebuild the case. A stabilization that recovers the $24.98 intermediate average, followed by closes back above SMA20, would be needed before a continuation reading could be reconsidered. On the operating side, the November 4 report would need to connect customer deployments to revenue, retention, margins and cash conversion. Repeating the size of Peacock’s audience cannot substitute for disclosed Fastly economics.

What would deepen the damage. Further closes below the $21.90 October 16 low would extend the reversal beyond this week’s range, and a declining intermediate average would turn a failed continuation into a broader downtrend. Demand variability, customer concentration, pricing pressure, security incidents and the costs of operating the network can change the business picture. A sharp rebound would also need new evidence before it could be read as more than a reaction to the decline.

How to read the next week. Last week’s text named a sharp return below $25.78, followed by loss of the $24.85 intermediate-average area, as the condition that would undermine the continuation thesis; both levels were lost. The case therefore stays in the list with a failed status for the audit, not as a renewed setup. A decline caused by changed company economics would require a different interpretation from a sector-wide repricing, and the November 4 report is the next point at which that distinction can be tested. Neither outcome implies an automatic action.

Primary sources: September 28 Comcast announcement · August 5 quarterly results · June 30 Form 10-Q · Issuer events calendar · October 8 earnings schedule · October 14 Form 4. Company figures retain the reporting dates stated above; all chart figures use October 16 prices.

Blue: SMA20. Purple: SMA50. Green candles close at or above their open; red candles close below it. Lower bars show each session’s share volume. The chart contains historical observations, with no projected prices.

Source: daily bars through October 16, 2026. Moving averages calculated by Merlintrader from the same series. The displayed window is July 24–October 16; earlier observations supply the averages.

$PENG · Penguin Solutions

Post-results reaction reversed · reassessment: The record-results advance gave back most of its gain

October 16 close $57.10 · SMA20 $62.29 · SMA50 $56.56 · volume/prior20 0.87×

Business evidence and timing. Penguin Solutions supplies AI infrastructure, memory and related technology. On October 6 it reported fiscal Q4 results for the period ended August 28: revenue of $566.7 million, GAAP operating income of $69.5 million and net income attributable to Penguin of $93.2 million. Management raised the fiscal 2027 revenue outlook to approximately $2.43 billion at the midpoint, with about 40% growth, plus or minus ten percentage points. These are reported historical results and a management forecast respectively; neither is an earnings event still pending next week. October 6 fiscal results.

The earnings headline needs a cash-flow check. The same release and SEC exhibit show fiscal Q4 operating cash use of $163.1 million and full-year operating cash use of $151.9 million. The quarter also included a $57.6 million income-tax benefit. August 28 cash was $647.2 million; current and long-term debt carrying amounts summed to about $789.0 million, a Merlintrader calculation. The company completed $750 million of zero-coupon convertible notes due 2031. Revenue growth is real, but the cash balance is not proof that the operating business funded itself, and a zero coupon does not remove principal repayment or potential dilution. SEC earnings exhibit.

Working capital is the operating question. Rapid hardware-related growth can absorb cash through inventories and receivables before collections arrive. The correct question is how shipments, collections, supplier payments and financing interact, rather than whether the earnings headline looks impressive. A tax benefit is a different contributor from recurring operating profit. Convertible financing can support expansion but changes the claims on future per-share value. These are reasons to examine cash conversion and capital structure alongside the revenue outlook; they are not a prediction that the growth program will fail.

The market response has reversed. PENG closed at $57.10 on October 16, below SMA20 $62.29 and just above SMA50 $56.56. After an intraday high of $80.47 on October 13, it fell 13.57% on October 14, 8.48% on October 15 and 7.69% on October 16. The October 9–16 price change was −25.14%, trailing IWM by 22.10 percentage points. Volume on October 14 and 15 was higher than on October 16, when it was 0.87 times the preceding 20-session norm. The close is now 8.33% below SMA20, compared with 32.66% above it a week earlier. Penguin’s SEC filing list shows no 8-K between October 7 and October 16, so the reversal is not tied to a new company disclosure in the primary record.

What would rebuild the case. Holding the $56.56 intermediate-average area and forming a new range would be the first condition; recovering SMA20 would be a second. Business confirmation would still require collections, cash conversion and financing to support the raised fiscal 2027 outlook. This edition does not treat the management growth midpoint as guaranteed sales and does not extrapolate one strong quarter into a multi-year valuation.

What would deepen the damage. Last week’s text named a reversal through the October 7 low of $65.70 or the October 6 close of $64.21 as the condition that would weaken the event reaction; both were breached on October 15. A sustained close below SMA50 and below the $56.60 October 6 low would erase the entire post-results move. Poor collections, renewed cash absorption, changes in demand, financing costs or dilution could outweigh a growth headline.

The next observation that matters. The research question has changed: whether the raised outlook can support a valuation after the post-results enthusiasm faded. A weaker market does not automatically invalidate operating progress, but this week showed how much optimism had been embedded in the move. PENG remains in the list with a reversed status so that the audit stays complete. No one-week success probability, price objective or undisclosed customer economics is assigned to it.

Primary sources: October 6 fiscal results · SEC earnings exhibit. Company figures retain the reporting dates stated above; all chart figures use October 16 prices.

Blue: SMA20. Purple: SMA50. Green candles close at or above their open; red candles close below it. Lower bars show each session’s share volume. The chart contains historical observations, with no projected prices.

Source: daily bars through October 16, 2026. Moving averages calculated by Merlintrader from the same series. The displayed window is July 24–October 16; earlier observations supply the averages.

The week ahead: confirmed dates and later earnings checks

Times are U.S. Eastern Daylight Time. Rome is six hours ahead through October 24 and five hours ahead from October 25 until the U.S. switch to standard time on November 1; the November 4 call is again six hours behind Rome. Scheduled releases can be revised. A date establishes when information may arrive, not the direction of the result.

Date and time	Verified event	What the research can assess
Mon Oct 19 · before market open; call 08:30 ET / 14:30 Rome	Cleveland-Cliffs Q3 results. Issuer announcement.	Shipments, realized prices, costs, cash generation and the next outlook can be set against the July guidance of about $575 million in third-quarter adjusted EBITDA. No result or market response is forecast.
Tue Oct 20 · 10:00 ET / 16:00 Rome	State Employment and Unemployment, September 2026. BLS October schedule.	Regional labor data provide macro context; they do not identify demand at an individual issuer.
Wed Oct 21 · 10:00 ET / 16:00 Rome	Usual Weekly Earnings of Wage and Salary Workers, Q3 2026. BLS October schedule.	Wage trends are background for consumer and services demand. The Friday October 23 close is the fixed endpoint of this edition’s forward price comparison.
Outside this week: Tue–Wed Oct 27–28	Federal Open Market Committee meeting. Federal Reserve calendar.	Rate expectations can change the valuation of growth and cyclical companies; the decision falls after this edition.
Outside this week: Wed Oct 28 · call 16:30 ET / 21:30 Rome	Everforth Q3 call; results and prepared remarks are posted before the call. Issuer announcement.	Bookings, funded task orders and federal versus commercial demand can test the contract narrative. It is not an October 19–23 catalyst.
Outside this week: Thu Oct 29 · after market close; call 16:30 ET / 21:30 Rome	SPS Commerce Q3 results. October 15 announcement.	Recurring revenue, monetization and the gap between GAAP and adjusted earnings; a later check on the consolidation case.
Outside this week: Wed Nov 4 · after market close; call 16:30 ET / 22:30 Rome	Fastly Q3 results. October 8 issuer announcement.	A later operating and cash-conversion check after the October reversal. It is not an October 19–23 earnings catalyst.

Previous-edition audit: keep the original dates and every case

The previous edition defined its forward interval as October 9 close to October 16 close. The table fills that exact interval for all five original names, with their original categories. The final column shows the October 2–9 week that preceded the edition; it is context, not part of the audit.

Original ticker	Original category	Oct 9 close · USD	Oct 16 close · USD	Fixed audit return	vs IWM · pp	Prior Oct 2–9 return
SPSC	Consolidation research	84.59	85.25	+0.78%	+3.83 pp	+2.72%
CLF	Cyclical earnings preview	12.98	12.12	-6.63%	-3.58 pp	+14.66%
EFOR	Trend continuation	37.50	38.36	+2.29%	+5.34 pp	+9.49%
FSLY	Event continuation	29.30	22.47	-23.31%	-20.26 pp	+13.52%
PENG	Post-results case	76.28	57.10	-25.14%	-22.10 pp	+24.32%
IWM	Benchmark	278.94	270.44	-3.05%	—	-0.92%

The unweighted average of the five cases was -10.40%, compared with IWM -3.05% over the identical interval. SPSC and EFOR gained while IWM fell; CLF lost more than the benchmark ahead of its results. The three non-technology cases averaged -1.18%, while FSLY and PENG averaged -24.23% and account for most of the shortfall. Removing them would turn a poor result into an acceptable one, which is why both stay in the record with their original labels.

This is an accountability check of dated research, not a trading record or backtested strategy. There were no published executed holdings, allocations, execution prices or trading costs. The losses in FSLY and PENG remain fully visible. Historical returns cannot establish the reliability of next week’s selection.

Other names checked: reasons and limits

These observations use the same October 16 cutoff. A name omitted from the developed five is not necessarily a poor company or a bearish forecast. Technical objections, incomplete business research and editorial capacity are different reasons; they are stated separately below.

Ticker or group	Observed reason for not developing a new case
SPNT	A +0.64% week, a close of $25.12 above SMA20 $24.99 and SMA50 $24.36, but an intermediate slope of only +0.37% and volume at 0.76× its prior-20 average. It does not add enough new evidence for a developed case.
AVT	The October 9–16 price change was −9.39%; the $90.03 close fell below SMA20 $100.08 and SMA50 $95.52.
BB	The stock lost 9.54% over the week and closed at $8.06, below SMA20 $8.72 and SMA50 $8.37; its old event case remains only in the historical audit.
INTR, STNE, SEZL, RXO	Last week’s large advances stalled or reversed: weekly changes were −12.37%, −9.47%, −0.77% and −1.65%. Distances above SMA20 are still 8.40%, 6.75%, 9.90% and 16.17%, and SEZL’s intermediate slope is -6.25%. They are not presented as developed cases.
MIR, BKV, MMS	MIR fell 8.84% and closed below SMA20; BKV fell 5.40% with a -0.65% intermediate slope; MMS rose 3.50% but its SMA50 slope is -1.23% and the price is 10.36% above SMA20.
TENB, QLYS	Both fell 10.56% on the week, with volume at 2.57× and 1.53× their prior-20 averages on October 16. TENB closed slightly below SMA20 and above SMA50; QLYS closed below both. They remain research alternatives to revisit, not asserted failures.
POWL, AMSC, EFXT	POWL (−13.96%) and AMSC (−15.89%) closed below both averages. EFXT rose 3.58% and closed above both averages with a +2.63% intermediate slope and 1.27× volume; it is noted as a research alternative rather than added, because this edition re-examines the existing five.
AIR, PRGS, CNXC	AIR closed below both averages. PRGS rose 3.84% and closed above SMA20 but below SMA50. CNXC rose 7.40% and closed above both averages, but on 0.51× its prior-20 volume; their completed reporting dates are not carried forward as future events.

How the numbers and charts were calculated

All displayed closes, daily chart candles and technical measures come from consolidated daily bars through October 16, 2026. The five charts display the latest 60 sessions; earlier observations supply the moving averages. SMA20 and SMA50 are arithmetic means of the latest 20 and 50 closes; the intermediate slope compares SMA50 with its value ten sessions earlier. Prices shown are completed-session closes, not live quotes or weekend/intraday prices.

Weekly price change = (October 16 close / October 9 close − 1) × 100. Relative strength is that stock return minus IWM’s return, in percentage points. Because the previous edition’s forward window was October 9 to October 16, the audit and the weekly change use the same interval this week. These are unweighted price-return comparisons, without reinvested dividends, transaction costs, slippage or a hypothetical executed position. A relative gain can coexist with an absolute loss.

Volume ratio = October 16 volume divided by the average of the preceding 20 sessions, excluding October 16. The separate liquidity figure is the average of the latest 20 sessions, including October 16. The prior-20-session high excludes October 16, while the ten-session low includes it. Distances above or below SMA20 describe extension, not fair value.

The October 9 closes and the October 9 SMA20 and SMA50 values recalculated from this week’s series match the figures published in the previous edition for all five cases and for IWM. Volume equivalence between different data providers is not claimed.

A dated screening snapshot supplies the indicative market capitalizations below. These are third-party estimates at October 16 prices, not a newly computed fully diluted valuation. They can differ from a calculation using an older SEC cover-page share count. Repurchases, issuance, stock compensation and convertible financing can change the relevant share base. The $300 million–$10 billion band is this rubric’s editorial definition, not a universal index classification.

Ticker	Indicative market value · October 16	Source and limitation
SPSC	$3.069 billion	Screening snapshot; common-equity estimate, not enterprise value or fully diluted value.
CLF	$6.915 billion	Screening snapshot; common-equity estimate, not enterprise value or fully diluted value.
EFOR	$1.573 billion	Screening snapshot; common-equity estimate, not enterprise value or fully diluted value.
FSLY	$3.579 billion	Screening snapshot; common-equity estimate, not enterprise value or fully diluted value.
PENG	$2.926 billion	Screening snapshot; common-equity estimate, not enterprise value or fully diluted value.

A selective weekly research filter

The aim is to improve the quality and traceability of research. A headline, a conference appearance, an analyst mention or a large weekly percentage alone is insufficient. Cases may have different risk profiles; any exception to the preferred filter is identified, rather than being presented as a fully qualified technical setup.

First: security, size and liquidity

U.S.-listed non-healthcare equities, price above $5 and an indicative $300 million–$10 billion common-equity value. The original selection requested positive weekly performance, price above SMA20/SMA50 and average volume above 500,000 shares. The developed cases were recalculated at one completed-session cutoff. SPSC’s latest 20-session volume average is below 500,000 shares, so its retained research status explicitly carries a liquidity caveat.

Second: evidence belonging to the issuer

Results, cash conversion, contract economics, financing and precise news dates. An IDIQ ceiling is not guaranteed revenue; a product launch is not quantified monetization; guidance is not a reported result. A tax benefit can lift net income without representing recurring operating profit. Each earnings and cash-flow figure refers to its own reporting period.

Third: demand for the shares

Relative strength, location against the averages, direction of the intermediate trend, participation and extension are assessed together. A positive percentage can coexist with weak volume or a stretched price. A breakout requires a close and subsequent acceptance. This week FSLY and PENG showed how quickly extended moves can reverse; their failed conditions are reported, not removed.

Fourth: observable failure and a fixed audit

Each case has price references and business risks that could change its interpretation. References are historical chart observations, not entry or stop orders. Every original name stays in the future comparison, including disclosed exceptions. One week’s outcome is too little evidence to establish a repeatable advantage.

No complete options-implied move, analyst-consensus model or positioning study is included. This edition therefore makes no quantified valuation-advantage claim, short-squeeze claim or success-probability estimate. Readers should add their own current information and risk assessment before any financial decision.

What each company report examines

Catalysts and contracts

Government awards, commercial wins, product launches, regulatory decisions and strategic milestones that can change what the market expects, each with the document that establishes it.

Earnings and execution

Revenue quality, margins, backlog conversion, guidance and the distance between what management said it would deliver and what it delivered.

Capital structure

Cash, runway, debt, share issuance, warrants, convertibles and the at-the-market programmes that quietly reshape per-share value.

Risk and volatility

Liquidity, valuation, concentration, ownership, insider activity and the specific events that would invalidate the prevailing narrative.

Sources and boundaries

• Company investor-relations announcements and SEC filings are linked beside the relevant cases. An issuer release and its SEC exhibit are two forms of the same management disclosure, not independent opinions.
• Consolidated daily bars supply the dated prices, candles and calculations; a dated screening snapshot supplies the capitalization estimates. No live-price claim is made.
• The BLS October release schedule and the Federal Reserve meeting calendar supply the macro dates. Company events calendars and announcements supply the verified later earnings dates.
• Technical interpretations, confirmation conditions and risk scenarios are Merlintrader analysis. They are distinguished from reported facts and management forecasts; unverified rumours, customer economics and analyst targets are not added.

Prepared October 17, 2026, with completed-session market data through October 16. Company financial periods and announcement dates are preserved individually. Later disclosures can change the assessment. No automatic follow-up or ongoing monitoring is implied.

Related research: Weekly Market Pulse, Insider Trading Weekly and Free Biotech Catalyst Calendar.

Get the weekly list as it goes live

Join the Merlintrader Telegram channel for the weekly list, market recaps and research updates the moment they are published.

Join @merlintraderpub_com on Telegram

Educational research only. This page is published for educational and informational purposes. It is not investment advice, not a recommendation, and not an offer or solicitation to buy or sell any security. Merlintrader is not a registered investment adviser or broker-dealer. Small and mid-cap securities can be highly volatile and may have limited liquidity. Company filings, market data and scheduled dates can be revised by the issuer or the agency that published them, and past performance does not indicate future results. Always do your own research and consult a licensed financial adviser before making any investment decision. Full disclaimer: merlintrader.com/disclaimer.

Merlintrader — educational use only. Community: r/MerlintraderPub · Telegram @merlintraderpub_com

Latest Small-Cap and Mid-Cap Research

• 
  Gravity ($GRVY) Deep Dive 2026: The Ragnarok Cash Machine — One Franchise, 91 Regions, And A Cash Pile Near Its Market Cap07/14/2026
  Gravity ($GRVY) deep dive: verified Q1 2026 and FY2025 numbers, ~$400M cash and no debt against a ~$440M market cap, the Ragnarok launch engine, GungHo control, and the bull vs bear case. Educational, not advice.
• 
  Rare Earth Independence Is Back: $USAR, $CRML and $MP Race to Rebuild the Western Supply Chain05/21/2026
  ENIT Rare Earth Reset · May 2026 · $USAR $CRML $MP Rare Earth Independence Is Back: $USAR, $CRML and $MP Race to Rebuild the Western Supply Chain USA Rare Earth, Critical Metals and MP Materials sit at three different points of the same strategic puzzle: mine-to-magnet integration, Greenland heavy rare earth feedstock, and America’s most… Read more: Rare Earth Independence Is Back: $USAR, $CRML and $MP Race to Rebuild the Western Supply Chain
• 
  USA Rare Earth Inc. (Nasdaq: $USAR): from strategic promise to execution pressure05/21/2026
  DOE selection, Q1 numbers, Stillwater magnet ramp, Round Top consolidation, Serra Verde, Carester and the real question for investors: can USA Rare Earth turn a heavily funded national-security story into a commercially disciplined mine-to-magnet platform?
• Asana Inc ( $ASAN ) Scaling SaaS & 2026 Growth Trajectory03/04/2026
  NYSE: ASAN · SaaS · Work Management Platform Asana Inc. (ASAN) – Scaling SaaS and 2026 Growth Trajectory SaaS deep-dive report – focus on product platform, financial performance, customer metrics and growth scenarios around FY2026 results and the FY2027 outlook. Report date: 4 March 2026 Financials updated through Q4 and full-year FY2026 (SEC filings) Educational… Read more: Asana Inc ( $ASAN ) Scaling SaaS & 2026 Growth Trajectory
• US Energy Corp ( $USEG )03/02/2026
  With oil back in focus after U.S.–Israeli strikes on Iran and renewed risk around the Strait of Hormuz, U.S. Energy Corp. (USEG) offers a very different angle from the majors: a small, vertically integrated platform trying to combine legacy oil and gas production with a large industrial gas and carbon management project at Kevin Dome in Montana. This is a deep dive into what USEG really is, how Kevin Dome fits into the 2026 energy landscape, and which catalysts matter from here.
• WAR US–Israel vs Iran, 2026 Small & mid-cap potential “winners & losers”03/02/2026
  Focus on factual developments of the last few days (Strait of Hormuz, tankers at anchor, oil spike) and on a sector-based watchlist – not on trying to predict the endgame of the conf
• T1 Energy Inc. ($TE) 02/17/2026
  Next business catalyst Late February 2026 – expected Q4 2025 earnings and business update, with more detail on 45X tax credit monetization, Giga America ramp and FEOC-compliant sourcing.
• RGTI Rigetti Computing Inc02/06/2026
  Rigetti is one of the few pure-play public quantum computing hardware names. It designs and manufactures superconducting quantum processors, integrates the control stack and cryogenics around them, and exposes these systems through a cloud platform so that enterprises, governments and researchers can experiment with quantum algorithms and hybrid quantum-classical workflows.
• BNAI Brand Engagement Network Inc01/31/2026
  In mid-January we covered BNAI as a tiny, risky AI play with a handful of real enterprise projects and a fragile balance sheet. Two weeks later the stock has printed a 52-week range from $1.18 to an intraday high above $80, short interest has exploded, and the company rushed out multiple press releases on licensing, warrant exercises, debt conversion and a premium private placement. This note is meant to put everything back into one framework: what BEN actually does, what changed in January, how stretched the valuation looks, and which hard catalysts matter once the trading dust settles.
• SKYX Platforms Corp01/30/2026
  SKYX wants to turn the ceiling into the “brain” of the home: a plug & play outlet that makes lights, fans and smart devices safer and easier to install, plus an AI-native platform built on NVIDIA’s cloud ecosystem. Revenues have climbed to record levels through Q3 2025 and the company has just secured new strategic and institutional funding ahead of big launches at Lowe’s and early smart city deployments.
• Space Defence & AI01/23/2026
  When you line up the numbers on artificial intelligence in space operations, autonomous systems and new-generation missile defence, it becomes very clear we are not looking at a “nice theme” to trade for a few quarters. We are watching the birth of a structural, AI-native arms race that stretches easily over the next 20–30 years.
• BNAI Brand Engagement Network DeepDive01/19/2026
  AI platform targeting highly regulated clients. Q4 2025 marked a “turning point”: a top-10 pharma engagement project, the Skye Salud sovereign healthcare JV in Mexico, and a first step in cleaning up a heavily diluted balance sheet.
• JFBR Jeffs Brands Ltd01/16/2026
  Jeffs’ Brands Ltd is a tiny Israeli micro-cap originally built around a data-driven Amazon FBA portfolio. That legacy business is still there: roughly $13.7M revenue in FY2024 against a net loss of about $7.8M, with a very small equity value and high operating leverage. The last twelve months have been brutal for long-term holders, with a price trajectory closer to a ski slope than a growth story.
• BNAI Brand Engagement Network Inc01/14/2026
  AI platform for regulated clients. Q4 2025 pivot built on a top-10 pharma engagement project, the Skye Salud sovereign healthcare JV in Mexico and a first step of balance-sheet clean-up with Nasdaq compliance restored.
• Briefing Space-AI-Defence stocks jan 1401/14/2026
  Briefing Space-AI-Defence stocks Jan 14 Daily overview on defence, space and AI-linked military names: Grok enters Pentagon networks, MBDA strengthens its position in Brazil and space small caps swing between rational euphoria and technical risk.
• DVLT Datavault AI Inc01/09/2026
  Datavault AI Inc. (Nasdaq: DVLT) is a small/micro-cap technology company that wants to sit at the intersection of AI, Web3 and data monetization. It licenses a portfolio of patents and software platforms to tokenize and value “real-world assets” (RWA) – from genomic data and prescription flows to commodities and luxury goods – and still carries the legacy wireless-audio business acquired from WiSA.
• SPACE & DEFENCE 202601/08/2026
  SIDU, ASTS, LUNR, ONDS and PL are not just “hot tickers”. Their satellites, landers, drones and imaging constellations are becoming building blocks of a Western answer to China’s dual-use space programs, Russia’s drone war and a world where infrastructure and data are contested every single day.
• HOVR New Horizon Aircraft Ltd01/05/2026
  Government money and Formula 1 DNA behind the Cavorite X7 In October 2025 Horizon announced an INSAT (Initiative for Sustainable Aviation Technology) grant to fund “Project CRYSTAL”, a 10.5 M CAD all-weather eVTOL programme focused on icing detection and protection. Horizon will receive about 2.0 M CAD in non-dilutive proceeds, working with the Flight Test Centre of Excellence (3C) and the University of Toronto on a propulsion system that can operate in conditions where most helicopters are grounded.
• OPEN Opendoor Technologies Inc01/03/2026
  Huge 2025 comeback – after trading below 1 USD, OPEN staged a massive rebound, with the share price up roughly 400–450% in 2025 on the back of retail enthusiasm, leadership changes and a “short squeeze” narrative. Real business, real losses – this is not a pre-revenue story. Opendoor generated 3.635B USD of revenue in the first nine months of 2025, but still reported a net loss of 204M USD over the same period. Heavy balance sheet usage – the company ended Q3 2025 with 962M USD of cash and 1.79B USD of debt, for a net cash position of about −830M USD. This is not an asset-light software-only model.
• TMC TMC the metals company Inc01/03/2026
  TMC is not a traditional small biotech or junior miner. It is a high-beta small/mid cap trying to open an entirely new segment: harvesting polymetallic nodules on the ocean floor in the Clarion-Clipperton Zone, with the idea of feeding the electric-vehicle and strategic metals supply chain.In 2025 the stock moved from just above 1 USD to a peak above 11 USD, closing the year still several hundred percent above the starting point. That kind of move puts TMC firmly on any “small caps of the moment” radar: strong narrative, strong retail interest, highly directional.